Sector revisions Anika Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-05 pm EST			5-day change	1st Jan Change
14.25 ^USD	-0.77%		+11.42%	+48.28%

Feb. 27	Barrington Adjusts Price Target on Anika Therapeutics to $17 From $16, Maintains Outperform Rating	MT
Feb. 27	B. Riley Adjusts Price Target on Anika Therapeutics to $18 From $16, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Nbr of analysts
ANIKA THERAPEUTICS, INC.					2
ABBOTT LABORATORIES					25
MEDTRONIC PLC					26
CENCORA, INC.					13
HOYA CORPORATION					15
BECTON, DICKINSON AND COMPANY					13
MEDLINE INC.	-	-	-	-	23
DEXCOM, INC.					26
STERIS PLC					8
SARTORIUS STEDIM BIOTECH					14
ZIMMER BIOMET HOLDINGS, INC.					23
TERUMO CORPORATION					13
WEST PHARMACEUTICAL SERVICES, INC.					14
INSULET CORPORATION					25
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED					12
ALIGN TECHNOLOGY, INC.					15
GLOBUS MEDICAL, INC.					13
SOLVENTUM CORPORATION					12
BAXTER INTERNATIONAL INC.					15
BIO-RAD LABORATORIES, INC.					5
Average					16
Weighted average by Cap.					20